2026-04-05T12:43:43Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/2228292025-12-04T23:44:15Zcom_2072_1057col_2072_478798col_2072_478916col_2072_478917

00925njm 22002777a 4500 dc García-Jiménez, Irene author Sans de San Nicolàs, Lídia author Díez-Ribas, Sandra author Curto-Barredo, Laia author Bertolín-Colilla, Marta author Vivancos-Melenchón, Ana author Figueras Nart, Ignasi author Bonfill Ortí, Montserrat author Ryzhkova, Anna author Ferran, Marta author Czarnowicki, Tali author Pujol Vallverdú, Ramón M. author Santamaria Babí, Luis F. author 2025-08-29T10:49:29Z 2025-08-29T10:49:29Z 2025-07-01 2025-08-29T10:49:29Z Background: Current understanding of IL-22 in atopic dermatitis (AD) mostly relies on animal models, intracellular staining of polyclonally activated peripheral lymphocytes, and biological therapies. Methods: We evaluated the IL-22 response to house dust mite (HDM) extract in 58 patients with moderate-to-severe AD using a coculture system made of circulating memory cutaneous lymphocyte associated antigen (CLA)+/- T cells with autologous lesional epidermal cells. Additionally, we performed histological and gene expression analysis in lesional skin biopsies, assessed specific IgE levels in plasma, and together with the clinical features of the patients, were related to the IL-22 in vitro response. Results: HDM triggered heterogeneous IL-22 secretion in memory T cells, preferentially in the CLA+ subset, which enabled patient stratification into IL22 producers (IL22P, n=17) and non-producers (IL22NP, n=41). IL22P showed an increased degree of epidermal thickness, overexpression of IL22 in lesional skin areas, elevated specific IgE levels against HDM and SEB in plasma, and a higher proinflammatory profile compared to IL22NP. Conclusions: This is the first report showing that allergen-specific CLA+ T-cell-mediated IL-22 in vitro response functionally distinguish moderate-to-severe adult AD patients with specific clinical features and activated IL-22 pathway in their lesional skin, paving the way for the selection of patients that may benefit from IL-22-directed therapies. Adults Immunoglobulines Antígens CD Dermatitis atòpica Adulthood Immunoglobulins CD antigens Atopic dermatitis Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin